62 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
be secured to fund those studies, and providing technology transfer, training and other support to be ready for clinical trial launch of RCS-01 and RCT
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
should partners be secured to fund those studies, and providing technology transfer, training and other support to be ready for clinical trial launch
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
of clinical studies in Japan for RCS-01 and RCT-01 should partners be secured to fund those studies, and (3) providing technology transfer, training
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
, training and other support to be ready for clinical trial launch of RCS-01 and RCT-01 in China with our partner, YOFOTO.
In combination with potential
20-F/A
0dr4ey7zluy n00
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
00fm2ptybfk0t0
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
uwrm0y5bqdkdk af
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
oas0 wvh1z853lpi
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
73zm1k
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.3
cf7r1wp60y7sjki
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.5
dohhpezy
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
ba9 rzfr3b
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
cg4xtdkx6s
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
ht7t5 d25
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
1bzamm
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
06n2agiv7v2uzc5j
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm